“Could glycated hemoglobin be considered a marker of inflammation in patients with diabetes mellitus?”, Int J Med Surg Sci, vol. 11, no. 2, pp. 1–13, Aug. 2024, doi: 10.32457/ijmss.v11i2.2619.